Navigation Links
8.3 Million U.S. Adults Considered Suicide Last Year
Date:9/17/2009

empted suicide (2 percent versus 0.3 percent).

"This study offers a far greater understanding of just how pervasive the risk of suicide is in our nation, and how many of us are potentially affected by it," Eric Broderick, SAMHSA acting administrator, said in a news release from the agency.

"While there are places that people in crisis can turn to for help like the National Suicide Prevention Lifeline [1-800-273-TALK], the magnitude of the public health crisis revealed by this study should motivate us as a nation to do everything possible to reach out and help the millions who are at risk -- preferably well before they are in immediate danger," Broderick said.

More information

The U.S. National Institute of Mental Health has more about suicide.



-- Robert Preidt



SOURCE: U.S. Substance Abuse and Mental Health Services Administration, news release, Sept. 17, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Chicago Lawyers Secure Record $25 Million Cook County Jury Verdict for Schaumburg Accident Victim
2. Relieving pain affecting millions
3. Malaria Control Method Could Prevent 6 Million New Infant Cases
4. CEL-SCI Corporation to Raise $20 Million in Registered Direct Offering
5. An Open Letter to Members of Congress: The Nearly 30 Million Americans With Rare Diseases Desperately Need Health Care Reform!
6. Video: Seventh Annual Avon Walk for Breast Cancer Los Angeles Raises More Than $4.6 Million
7. Center for AIDS Intervention Research Medical receives $11.16 million NIH grant
8. By 2018, GlaxoSmithKlines Votrient Will Garner Sales of $640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader
9. U.S. Food and Drug Administration Clears Vermillions OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass
10. DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million
11. CBM-US Receives $3 Million Grant To Fund HIV/AIDS Prevention and Care Efforts in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... NY (PRWEB) , ... August 04, 2015 , ... ... vegetarian capsule formula. Healthy Origins® Cognizin® is a trademark for Citicoline, a ... base for a capsule for those applications which have more of a semi-solid ...
(Date:8/4/2015)... ... August 04, 2015 , ... An article published July 27th by ... viable method for encouraging people to lose weight. Specifically the study compared control patients ... loss success, adding a financial incentive to the overall incentive of increased health. According ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... commercial customers. Finding reliable hardware can be difficult and troublesome for companies. ... an office together or designing a new facility, it is imperative to include ...
(Date:8/4/2015)... ... August 04, 2015 , ... Bayco Products, Inc. announces a new industrial-grade LED ... on hard hats that have a flip-up face shield. The sleek contours of the ... without having to remove their headlamp when raising or lowering their face shield or ...
(Date:8/4/2015)... ... , ... Angelina Jolie is in it at age 39. “It” is menopause, ... Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s leading ... menopause. , Myth #1: Menopause only affects old ladies. – Menopause can affect ...
Breaking Medicine News(10 mins):Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3
... Bad Reactions to FDA Safety,Program, WASHINGTON, April 2, 2008 ... Americans who have ever taken a,prescription drug experienced a side ... but the majority of consumers don,t know they can,report these ... safety problems., To help make the public aware of ...
... 2, 2008) Dr. Richard Stein, a professor emeritus ... Dentistry, has been named the 2007 recipient of the ... prize is presented annually to the top ranked spinal ... Research,s (CIHR) investigator-initiated grants competition. , Stein ...
... WEDNESDAY, April 2 (HealthDay News) -- Two well-known HIV ... of heart attacks, European researchers reported Wednesday. , Based ... is now conducting a safety review of the potential ... take a combination of antiretroviral drugs, which include a ...
... GXDX ) today announced that the company,s 2008 annual meeting,of ... June 17, 2008 at,the company,s headquarters in Carlsbad, CA., ... business on,April 25, 2008 as the record date for the ... to vote at, the annual meeting., About Genoptix, Inc., ...
... ORLANDO, Fla., April 2, 2008 The American,Red ... assistance and,other benefits to Hurricane Katrina and Rita ... Louisiana and south Mississippi. These,funds, initially set aside ... are being used to bolster existing individual,assistance through ...
... YORK, April 2, 2008 Easter Seals is shining ... among the,vast array of services the national nonprofit provides ... the last 20 years, Easter Seals has seen a ... autism the organization serves.,Today, as many as one in ...
Cached Medicine News:Health News:Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects 2Health News:Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects 3Health News:Alberta physiologist earns top national honor for spinal cord research 2Health News:HIV Drugs Linked to Increased Risk of Heart Attack 2Health News:HIV Drugs Linked to Increased Risk of Heart Attack 3Health News:In Face of Continuing Katrina and Rita Needs Red Cross Adds Resources to Gulf Coast 2Health News:In Face of Continuing Katrina and Rita Needs Red Cross Adds Resources to Gulf Coast 3Health News:Easter Seals Celebrates World Autism Awareness Day With Campaign to Highlight Nationwide Services Available to Families Living With Autism Today 2
(Date:8/4/2015)...  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... commercialization of targeted antiviral therapies, today announced that ... live at VirtualInvestorConferences.com on August 6, 2015. ... EDT LINK: http://tinyurl.com/aug6-pre-ctrv ... where investors are invited to ask the company ...
(Date:8/4/2015)... IRVINE, Calif., Aug. 4, 2015  Syneron Medical Ltd. (NASDAQ: ... announced financial results for the three month period ended June ... Recent Non-GAAP 1 Highlights: , ... constant currency. , North American product sales grew 45% ... in constant currency, including 14% product growth in the EMEA ...
(Date:8/3/2015)...  Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... the fiscal third quarter 2015 after the market close ... Company will also host a conference call for investors ... Time (10:00 a.m. Eastern Time). Investors may access the ...
Breaking Medicine Technology:ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2
... Vical Incorporated,(Nasdaq: VICL ) today announced ... independently produced video report featuring metastatic,melanoma patients treated ... is expected to be used,broadly by stations in ... Allovectin-7(R) trial, and in other cities by stations ...
... III Results Demonstrate Superior Reduction in In-Segment Late Loss, Non-Inferiority in ... ... V Compared to TAXUS, ABBOTT PARK, Ill., April ... Association (JAMA) demonstrated,that use of Abbott,s XIENCE(TM) V Everolimus Eluting Coronary ...
Cached Medicine Technology:Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 2Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 3Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 4Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 5Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5
A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
Sinus Trocar and Cannula, 4 mm...
1.0 mm diameter head, 0.75 mm deep bite....
Kelly Punches...
Medicine Products: